BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30392137)

  • 1. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs.
    Kiran M; Chatrath A; Tang X; Keenan DM; Dutta A
    Mol Neurobiol; 2019 Jul; 56(7):4786-4798. PubMed ID: 30392137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
    Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
    Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of Long Non-Coding RNA AB073614 Predicts a Poor Prognosis in Patients with Glioma.
    Hu L; Lv QL; Chen SH; Sun B; Qu Q; Cheng L; Guo Y; Zhou HH; Fan L
    Int J Environ Res Public Health; 2016 Apr; 13(4):433. PubMed ID: 27104549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foreboding lncRNA markers of low-grade gliomas dependent on metabolism.
    Lu Z; Feng Y
    Medicine (Baltimore); 2022 Nov; 101(44):e31302. PubMed ID: 36343057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NDUFA6-DT: A Comprehensive Analysis of a Potential LncRNA Biomarker and Its Regulatory Mechanisms in Gliomas.
    Huang R; Kong Y; Luo Z; Li Q
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of immune-related lncRNA in low-grade glioma.
    Li X; Meng Y
    BMC Cancer; 2019 Aug; 19(1):813. PubMed ID: 31419958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune-related lncRNA signature for patients with anaplastic gliomas.
    Wang W; Zhao Z; Yang F; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
    J Neurooncol; 2018 Jan; 136(2):263-271. PubMed ID: 29170907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas.
    Wang W; Yang F; Zhang L; Chen J; Zhao Z; Wang H; Wu F; Liang T; Yan X; Li J; Lan Q; Wang J; Zhao J
    Oncotarget; 2016 Nov; 7(47):77225-77236. PubMed ID: 27764782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.
    Reon BJ; Anaya J; Zhang Y; Mandell J; Purow B; Abounader R; Dutta A
    PLoS Med; 2016 Dec; 13(12):e1002192. PubMed ID: 27923049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
    Chen XD; Zhu MX; Wang SJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas.
    Isaev K; Jiang L; Wu S; Lee CA; Watters V; Fort V; Tsai R; Coutinho FJ; Hussein SMI; Zhang J; Wu J; Dirks PB; Schramek D; Reimand J
    Cell Rep; 2021 Oct; 37(3):109873. PubMed ID: 34686327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
    Gong Z; Hong F; Wang H; Zhang X; Chen J
    BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.